We serve Chemical Name:potassium,trifluoro-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]boranuide CAS:1023357-66-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:potassium,trifluoro-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]boranuide
CAS.NO:1023357-66-5
Synonyms:potassium 3-trifluoroboratopropionate tert-butyl ester;c-2138
Molecular Formula:C7H13BF3KO2
Molecular Weight:236.08100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:26.30000
Exact Mass:236.06000
LogP:2.56560
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like potassium 3-trifluoroboratopropionate tert-butyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,c-2138 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,potassium 3-trifluoroboratopropionate tert-butyl ester Use and application,c-2138 technical grade,usp/ep/jp grade.
Related News: It has contracted with the Chinese manufacturer Xiamen Biotime Biotechnology to produce the tests for international distribution. According to Innova, Biotime previously submitted performance data to the agency without seeking an EUA, while the company later presented equivalent data for the same test under the Innova brand. potassium,trifluoro-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]boranuide manufacturer Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. potassium,trifluoro-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]boranuide supplier Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process. potassium,trifluoro-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]boranuide vendor Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process. potassium,trifluoro-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]boranuide factory It has contracted with the Chinese manufacturer Xiamen Biotime Biotechnology to produce the tests for international distribution. According to Innova, Biotime previously submitted performance data to the agency without seeking an EUA, while the company later presented equivalent data for the same test under the Innova brand.